These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31959918)

  • 1. Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation.
    Li R; Chen S; Zhan J; Li X; Liu W; Sheng X; Lu Z; Zhong R; Chen L; Luo X; Hu Y; Ouyang Y; Liu T; Zhang Q; Zhang S
    Cell Death Dis; 2020 Jan; 11(1):41. PubMed ID: 31959918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long noncoding RNA ST7-AS1 promotes laryngeal squamous cell carcinoma by stabilizing CARM1.
    Qin H; Xu J; Gong L; Jiang B; Zhao W
    Biochem Biophys Res Commun; 2019 Apr; 512(1):34-40. PubMed ID: 30853182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FOXD2-AS1 is corelated with clinicopathological parameter of laryngeal carcinoma and promote cancer cell proliferation].
    Chen W; Sun SG; Jiang MX; Li SS; Yuan K
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 33(5):436-440. PubMed ID: 31163553
    [No Abstract]   [Full Text] [Related]  

  • 4. LINC00319 promotes cancer stem cell-like properties in laryngeal squamous cell carcinoma via E2F1-mediated upregulation of HMGB3.
    Yuan L; Tian X; Zhang Y; Huang X; Li Q; Li W; Li S
    Exp Mol Med; 2021 Aug; 53(8):1218-1228. PubMed ID: 34408262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA AFAP1-AS1/miR-320a/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance.
    Yuan Z; Xiu C; Song K; Pei R; Miao S; Mao X; Sun J; Jia S
    J Cell Mol Med; 2018 Sep; 22(9):4253-4262. PubMed ID: 29971915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.
    Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L
    Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
    Gu N; Wang X; Di Z; Xiong J; Ma Y; Yan Y; Qian Y; Zhang Q; Yu J
    Aging (Albany NY); 2019 Nov; 11(22):10266-10283. PubMed ID: 31770107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXD2-AS1 Predicts Dismal Prognosis for Oral Squamous Cell Carcinoma and Regulates Cell Proliferation.
    Liang X; Chen Z; Wu G
    Cell Transplant; 2020; 29():963689720964411. PubMed ID: 33103475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
    Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of lncRNA SBF2-AS1 regulates the miR-302b-3p/TGFBR2 axis, promoting metastasis in laryngeal cancer.
    Li Y; Tang B; Lyu K; Yue H; Wei F; Xu Y; Chen S; Lin Y; Cai Z; Guo X; Li C; Lei W
    Mol Carcinog; 2022 Jan; 61(1):45-58. PubMed ID: 34644425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
    Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
    Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
    Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis.
    Xu Z; Xi K
    Biomed Pharmacother; 2019 Oct; 118():109222. PubMed ID: 31351424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370.
    Cui X; Yu H; Yu T; Xiao D; Wang X
    Aging (Albany NY); 2021 Mar; 13(7):9900-9910. PubMed ID: 33882027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H19/miR-107/HMGB1 axis sensitizes laryngeal squamous cell carcinoma to cisplatin by suppressing autophagy in vitro and in vivo.
    Chen L; Xu Z; Zhao J; Zhai X; Li J; Zhang Y; Zong L; Peng H; Qi J; Kong X; Fang Z; Liu M
    Cell Biol Int; 2021 Mar; 45(3):674-685. PubMed ID: 33314408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of long non-coding RNA FOXD2-AS1 promotes progression and predicts poor prognosis in tongue squamous cell carcinoma.
    Zhou G; Huang Z; Meng Y; Jin T; Liang Y; Zhang B
    J Oral Pathol Med; 2020 Nov; 49(10):1011-1018. PubMed ID: 32531865
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhang L; Bo H; Chen T; Li Q; Huan Y; Zhang S
    Future Oncol; 2020 Oct; 16(28):2209-2218. PubMed ID: 32762453
    [No Abstract]   [Full Text] [Related]  

  • 18. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
    Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
    Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21.
    Ren Z; Hu Y; Li G; Kang Y; Liu Y; Zhao H
    Biomed Pharmacother; 2019 Sep; 117():109104. PubMed ID: 31228799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma.
    Sui C; Dong Z; Yang C; Zhang M; Dai B; Geng L; Lu J; Yang J; Xu M
    J Cell Mol Med; 2019 Sep; 23(9):6024-6033. PubMed ID: 31210410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.